Perspective Therapeutics (CATX) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Perspective Therapeutics (CATX) over the last 15 years, with Q3 2025 value amounting to -$297.4 million.
- Perspective Therapeutics' Retained Earnings fell 5521.92% to -$297.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$297.4 million, marking a year-over-year decrease of 5521.92%. This contributed to the annual value of -$231.7 million for FY2024, which is 5200.67% down from last year.
- As of Q3 2025, Perspective Therapeutics' Retained Earnings stood at -$297.4 million, which was down 5521.92% from -$271.4 million recorded in Q2 2025.
- Over the past 5 years, Perspective Therapeutics' Retained Earnings peaked at -$90.3 million during Q1 2021, and registered a low of -$297.4 million during Q3 2025.
- For the 5-year period, Perspective Therapeutics' Retained Earnings averaged around -$150.6 million, with its median value being -$117.4 million (2023).
- As far as peak fluctuations go, Perspective Therapeutics' Retained Earnings tumbled by 385.16% in 2021, and later crashed by 5521.92% in 2025.
- Over the past 5 years, Perspective Therapeutics' Retained Earnings (Quarter) stood at -$95.2 million in 2021, then dropped by 11.31% to -$105.9 million in 2022, then plummeted by 43.9% to -$152.4 million in 2023, then tumbled by 52.01% to -$231.7 million in 2024, then dropped by 28.35% to -$297.4 million in 2025.
- Its last three reported values are -$297.4 million in Q3 2025, -$271.4 million for Q2 2025, and -$249.9 million during Q1 2025.